Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes.
暂无分享,去创建一个
S. Fukushima | A. Kinoshita | R. Puatanachokchai | H. Wanibuchi | K. Morimura | Y. Funae | M. Oka | S. Yamaguchi | Fukui Mitsuru | Anna Kinoshita
[1] W. Waddell. Comparisons of thresholds for carcinogenicity on linear and logarithmic dosage scales , 2005, Human & experimental toxicology.
[2] Christopher J. Rhodes,et al. Role of oxygen radicals in DNA damage and cancer incidence , 2004, Molecular and Cellular Biochemistry.
[3] J. Klaunig,et al. The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.
[4] S. Fukushima,et al. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. , 2003, Carcinogenesis.
[5] Frank Bretz,et al. Statistical Analysis of Monotone or Non-monotone Dose–Response Data from In Vitro Toxicological Assays , 2003, Alternatives to laboratory animals : ATLA.
[6] T. Tsukamoto,et al. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. , 2003, Cancer letters.
[7] Edward J Calabrese,et al. Toxicology rethinks its central belief , 2003, Nature.
[8] Tomoyuki Shirai,et al. A medium‐term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals , 2003, Cancer science.
[9] Q. Su,et al. Significance of Hepatic Preneoplasia in Risk Identification and Early Detection of Neoplasia * , 2003, Toxicologic pathology.
[10] Hiroyuki Tsuda,et al. Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work , 2003, Toxicologic pathology.
[11] T. Tsukamoto,et al. Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine , 2002, Japanese journal of cancer research : Gann.
[12] S. Fukushima,et al. Detailed low‐dose study of 1,1‐b™IS(p‐chlorophenyl)‐2,2,2‐ trichloroethane carcinogenesis suggests the possibility of a hormetic effect , 2002, International journal of cancer.
[13] J. Gastel. Early indicators of response in biologically based risk assessment for nongenotoxic carcinogens. , 2001, Regulatory toxicology and pharmacology : RTP.
[14] E J Calabrese,et al. Hormesis: U-shaped dose responses and their centrality in toxicology. , 2001, Trends in pharmacological sciences.
[15] S. Fukushima,et al. Presence of a no-observed effect level for enhancing effects of development of the α-isomer of benzene hexachloride (α-BHC) on diethylnitrosamine-initiated hepatic foci in rats , 2001 .
[16] R. Schulte‐Hermann,et al. Biology of transforming growth factor β in hepatocarcinogenesis , 2001, Microscopy research and technique.
[17] I. Rusyn,et al. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. , 2000, Carcinogenesis.
[18] Chung-Xiou Wang,et al. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds , 1999, Archives of Toxicology.
[19] T. Sueyoshi,et al. The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene , 1998, Molecular and Cellular Biology.
[20] W. Lutz,et al. Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. , 1998, Mutation research.
[21] H. Wanibuchi,et al. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. , 1998, Carcinogenesis.
[22] H. Kasai,et al. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. , 1997, Mutation research.
[23] Y. Konishi,et al. Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. , 1995, Cancer letters.
[24] A. Kopp-Schneider,et al. Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis. , 1995, Carcinogenesis.
[25] I. Shaw,et al. Mechanisms of non-genotoxic carcinogenesis. , 1994, Trends in pharmacological sciences.
[26] R. Setzer,et al. Dose-response relationship in multistage carcinogenesis: promoters. , 1994, Environmental health perspectives.
[27] J Ashby,et al. Determination of the genotoxic status of a chemical. , 1991, Mutation research.
[28] S. Imaoka,et al. Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation. , 1990, Archives of biochemistry and biophysics.
[29] M. Tatematsu,et al. Correlation between medium-term liver bioassay system data and results of long-term testing in rats. , 1990, Carcinogenesis.
[30] T. Lee,et al. Structural and functional analysis of NADPH-cytochrome P-450 reductase from human liver: complete sequence of human enzyme and NADPH-binding sites. , 1989, Biochemistry.
[31] B. Ames,et al. Endogenous DNA damage as related to cancer and aging. , 1989, Mutation research.
[32] M. Tatematsu,et al. Medium-Term Bioassay System for Detection of Carcinogens and Modifiers of Hepatocarcinogenesis Utilizing the GST-P Positive Liver Cell Focus as an Endpoint Marker∗ , 1989, Toxicologic pathology.
[33] S. Imaoka,et al. Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. , 1985, Biochimica et biophysica acta.
[34] N. Bhamarapravati,et al. Further study of alpha benzene hexachloride inhibition of aflatoxin B1 hepatocarcinogenesis in rats. , 1981, British Journal of Cancer.
[35] B. Gross,et al. The elevation of rat liver glutathione-S-transferase activity by alpha-hexachlorocyclohexane. , 1981, Biochemical pharmacology.
[36] N. Ito,et al. Development of hepatocellular carcinomas in rats treated with benzene hexachloride. , 1975, Journal of the National Cancer Institute.
[37] N. Ito,et al. The inhibitory effects of alpha-benzene hexachloride on 3'-methyl-4-dimethylaminoazobenzene and DL-ethionine carcinogenesis in rats. , 1974, Cancer research.
[38] T. Omura,et al. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.
[39] T. Omura,et al. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. , 1964, The Journal of biological chemistry.
[40] S. Toyokuni,et al. Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. , 2004, Cancer letters.
[41] R. Conolly,et al. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[42] B. Diwan,et al. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B. , 1996, Carcinogenesis.
[43] M. P. Arlotto,et al. Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. , 1991, Methods in enzymology.
[44] R. Schulte‐Hermann,et al. Dose-response studies on the effects of alpha-, beta-, and gamma-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver. , 1987, Cancer research.
[45] A. Hayes. Principles and methods of toxicology , 1982 .
[46] W. Jakoby,et al. Assays for differentiation of glutathione S-transferases. , 1981, Methods in enzymology.